200 related articles for article (PubMed ID: 21969911)
61. Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report.
Lemal R; Chaleteix C; Minard P; Roche C; Bay JO; Tournilhac O; Lamy T
Leuk Res Rep; 2013; 2(1):32-3. PubMed ID: 24371773
[TBL] [Abstract][Full Text] [Related]
62. Antibodies to active zone protein ERC1 in Lambert-Eaton myasthenic syndrome.
Huijbers MG; Lipka AF; Potman M; Hensbergen PJ; Titulaer MJ; Niks EH; van der Maarel SM; Klooster R; Verschuuren JJ
Hum Immunol; 2013 Jul; 74(7):849-51. PubMed ID: 23583364
[TBL] [Abstract][Full Text] [Related]
63. Lambert-Eaton myasthenic syndrome as an autoimmune calcium-channelopathy.
Takamori M; Maruta T; Komai K
Neurosci Res; 2000 Mar; 36(3):183-91. PubMed ID: 10683522
[TBL] [Abstract][Full Text] [Related]
64. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
65. [Diagnosis and Treatment of Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Yoshimura S; Shiraishi H; Motomura M
Brain Nerve; 2024 Jan; 76(1):33-40. PubMed ID: 38191137
[TBL] [Abstract][Full Text] [Related]
66. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer.
Wang S; Bruzzi J; Rodriguez-Garza VP; Komaki RR
Clin Lung Cancer; 2006 Jan; 7(4):282-4. PubMed ID: 16512985
[TBL] [Abstract][Full Text] [Related]
67. The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma.
Briggs SE; Gozzard P; Talbot DC
Immunotargets Ther; 2013; 2():31-7. PubMed ID: 27471686
[TBL] [Abstract][Full Text] [Related]
68. [Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].
Boutin E; Rey C; Romeu M; Pouget J; Franques J
Rev Med Interne; 2013 Aug; 34(8):493-6. PubMed ID: 23759215
[TBL] [Abstract][Full Text] [Related]
69. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
[TBL] [Abstract][Full Text] [Related]
70. Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: a call for caution.
Di Lorenzo R; Mente K; Li J; Shayya L; Rae-Grant A; Li Y; Jammoul A
J Neurol; 2018 Sep; 265(9):2114-2119. PubMed ID: 29987589
[TBL] [Abstract][Full Text] [Related]
71. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
Takamori M; Iwasa K; Komai K
Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453
[TBL] [Abstract][Full Text] [Related]
72. Lambert-Eaton myasthenic syndrome.
Mareska M; Gutmann L
Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511
[TBL] [Abstract][Full Text] [Related]
73. Muscular pathological features in patients with Lambert-Eaton myasthenic syndrome associated with small cell lung carcinoma.
Zhang Y; Ban R; Pu C; Shi Q
Clin Neuropathol; 2021; 40(2):93-97. PubMed ID: 32831159
[TBL] [Abstract][Full Text] [Related]
74. Successful treatment of advanced lung adenocarcinoma complicated with Lambert-Eaton myasthenic syndrome: A case report and literature review.
Wang A; Zhang X; Yi J; Zhu M; Zhang Y
Thorac Cancer; 2020 May; 11(5):1334-1338. PubMed ID: 32154996
[TBL] [Abstract][Full Text] [Related]
75. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.
Wirtz PW; Nijnuis MG; Sotodeh M; Willems LN; Brahim JJ; Putter H; Wintzen AR; Verschuuren JJ;
J Neurol; 2003 Jun; 250(6):698-701. PubMed ID: 12796832
[TBL] [Abstract][Full Text] [Related]
76. Long-Standing Lambert-Eaton Myasthenic Syndrome Caused by Undetectable Small-Cell Lung Cancer: Why We Should Follow-Up LEMS.
Hong BY; An HJ; Lim SH
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885447
[TBL] [Abstract][Full Text] [Related]
77. Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome.
Bukhari S; Soomro R; Fawwad S; Alvarez C; Wallach S
J Investig Med High Impact Case Rep; 2017; 5(3):2324709617721251. PubMed ID: 28785598
[TBL] [Abstract][Full Text] [Related]
78. Increased frequency of HLA class II alleles DRB1*0301 and DQB1*0201 in Lambert-Eaton myasthenic syndrome without associated cancer.
Parsons KT; Kwok WW; Gaur LK; Nepom GT
Hum Immunol; 2000 Aug; 61(8):828-33. PubMed ID: 10980394
[TBL] [Abstract][Full Text] [Related]
79. A Rare Case of Lambert-Eaton Myasthenia Syndrome Associated with Non-Hodgkin's Lymphoma: A Case Report and Review of the Literature.
Abu-Tineh M; Alamin MA; Aljaloudi E; Alshurafa A; Garcia-Cañibano B; Taha RY; Elkourashy SA
Case Rep Oncol; 2023; 16(1):1300-1305. PubMed ID: 37942405
[TBL] [Abstract][Full Text] [Related]
80. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
